Comments

Response to Comment on: “Avatrombopag as a novel salvage therapy for refractory thrombocytopenia in THPO-mutated congenital amegakaryocytic thrombocytopenia after allogeneic hematopoietic stem cell transplantation”

Department of Hematology, Qilu Hospital of Shandong University, Qingdao, Shandong
Department of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai
Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai
Haematologica Early view Nov 12, 2026 https://doi.org/10.3324/haematol.2026.302256